Eight individuals and two teams involving Imperial researchers have won accolades in this year’s RSC prizes The Royal Society of Chemistry (RSC) has announced the winners of its prestigious 2024 prizes With 10 winners from the Departments of Chemistry this year has been a record-breaking one for Imperial The winners have been recognised for their outstanding contributions to various fields Professor Ian Walmsley said: “We celebrate an exceptional achievement this year with so many of our brilliant researchers being honoured with Royal Society of Chemistry prizes “Their pioneering work spans a remarkable range of disciplines underscoring the interdisciplinary nature of modern scientific inquiry These awards not only highlight the invaluable contributions of chemistry to innovation and research but also reinforce the pivotal role Imperial’s academics play in advancing knowledge and addressing global challenges.” Dr Maxie Roessler, from the Department of Chemistry, has won the Joseph Black Prize for the development of advanced electron paramagnetic resonance (EPR) spectroscopy to investigate structurally define and exploit catalysis by chemical and biological systems Dr Roessler also receives £3,000 and a medal Magnetic resonance is widely used in science and medicine, including MRI in hospitals and advanced spectroscopy. Dr Roessler's research group focuses on electron paramagnetic resonance (EPR) to study materials and molecules with unpaired electrons, particularly in enzymes. This research could lead to advancements in sustainability and healthier ageing Dr Roessler said: “After surprise and disbelief Grateful to everyone who supported me in my journey so far I was lucky to have a very supportive PhD supervisor I am lucky to be part of a very inspiring community not only every day at Imperial but also more widely in EPR spectroscopy and bioinorganic chemistry and I am very happy that our work has been recognised in this way: when I first started talking about wanting to develop a method that allows watching electrons in real time during electrochemical (catalytic) reactions I guess the prize gives me some confidence to pursue this direction and to make it work for enzymes science is also very much about the people I also feel that the prize is not just for me – everyone who worked with me owns a little part of it most and foremost my research group members Dr Nicola Gasparini, from the Department of Chemistry, has won the Materials Chemistry Early Career Prize for his work in understanding processes in materials for advanced solar cells and light detectors Dr Gasparini investigates charge recombination processes in thin-film organic and perovskite semiconductor materials used in solar and photodetector applications These materials are about as thin as a human hair and yet they can conduct electricity and convert light into usable current and cost-effective for large-area manufacturing They can also convert weak indoor light into electricity more efficiently than other photovoltaic (PV) technologies These technologies are essential in society for cost-effective, reliable, durable, and efficient devices and for more sustainable energy generation solutions that can replace Dr Gasparini commented: “I am delighted to receive the Materials Chemistry Early Career Prize This is a milestone for my career and for my group This prize is the coronation of my collaborative work with many talented people that have crossed my academic life.” Potential uses of these micro-robots include targeted drug delivery within the body and environmental monitoring.After receiving the prize Dr Elani said: “It is a joy and a privilege to receive this prize I am thrilled to see the hard work of our entire team recognized in such a significant way I mean it in the broadest sense – our PhD students and academic collaborators who have all been deeply involved in every step of our research.” Professor Marina Kuimova, from the Department of Chemistry, has won the Corday-Morgan Mid-Career Prize for the development of unique probes and methodologies in fluorescence imaging leading to an understanding of dynamic biological processes in living systems pertinent to health and disease She also receives £5,000 and a medal Professor Kuimova commented: “I am absolutely delighted that my work and the work of my group have been recognised by the Corday-Morgan Prize This sign of recognition will fuel us to do more and collaborate even more widely developing our probes and techniques to try to tackle mysteries of chemistry and biology.”  Dr Felice Torrisi, from the Department of Chemistry, has won a Harrison-Meldola Early Career Prize for innovative contributions to the understanding of charge transport in networks of two-dimensional materials to develop printed electronics Dr Torrisi said: “I am thrilled to be awarded the Harrison-Meldola Prize I am grateful to the collaborators and funders who supported my work and I am so proud of the research group I am working with daily.” low carbon bio-renewable feedstocks and from a linear to a circular manufacturing economy He has developed a unique technology that uses multiple feedstocks (wood and waste) to ensure the continued growth of this thriving industry base without compromising global sustainability efforts.After receiving the prize Professor Hallet said: “I was positively thrilled to receive the RSC ESE Open Prize for the Environment The Royal Society of Chemistry is an outstanding organisation pushing forward the entirety of the chemistry professions and the list of past winners of this award that I am joining is a humbling experience My work is motivated by a drive to improve the impact of humans on the environment and to be recognised with a prize in this exact area is a major career highlight.” Dr Schumann also receives £3,000 and a medal Dr Schumann said: “I am excited and extremely grateful to the Royal Society of Chemistry This award is a testament to the ever-increasing need for chemical methods to understand what glycans do Our work would not be possible without my amazing team members Professor Jenny Nelson, from the Department of Physics, has won the Faraday Lectureship Prize for contributions to the understanding and development of novel electronic materials for solar energy conversion Professor Nelson also receives £3,000 and a medal She investigates new materials for solar energy conversion, including taking inspiration from nature cheaper and more flexible materials to make solar cells have been developed over recent years but these often lack performance and stability Much of the early improvements in design were achieved through trial and error but Professor Nelson has pioneered approaches to rationally design new photovoltaics based on an understanding of their functioning principles The A-WOL Antifilarial Drug Discovery Team is a collaboration between the University of Liverpool University of Bonn and industrial partners from Astra Zeneca and Eisai Ltd They have won a Horizon Prize for discovering fast-acting, highly specific anti-Wolbachia candidates for the oral treatment of lymphatic  filariasis (elephantiasis) and onchocerciasis (river blindness) The winners also receive a trophy and individual recognition for their contribution these diseases result in devastating health impacts for more than 150 million people in some of the poorest countries worldwide The team’s collaborative research in drug discovery has resulted in the development of the first synthetic drug candidate the bacteria that the parasitic worms rely on  Wolbachia is required to maintain the worms’ fertility so that eliminating these bacteria safely sterilises the female parasite without causing the damaging inflammation that can result from directly killing the worms Professor Ed Tate one of the co-leads from Imperial’s Department of Chemistry said: “The Horizon Prize is a huge tribute to the multidisciplinary and international team of drug discovery scientists at Liverpool Imperial and beyond who have worked over many years to demonstrate the feasibility of targeting an extraordinary Achilles heel in parasitic nematode worms “I am delighted that my group had the opportunity to contribute towards our understanding of how these agents work and proud of the team which has now progressed their compounds into clinical trials opening a new chapter in the fight against river blindness and elephantiasis.” The ReLiB (Reuse & Recycling of Lithium-Ion Batteries) team have won a Horizon Prize for transformative research and influence leading to the establishment of a technology pipeline for low-cost and low environmental impact lithium-ion battery recycling The team receive a trophy and a video showcasing their work and each team member receives a certificate The team is a multidisciplinary collaboration between Imperial College London The ReLiB project focuses on reducing the steps needed to remanufacture end-of-life (EoL) materials into new battery cells The team believes that highly efficient recycling methods with exceptional material recovery rates are crucial to preventing significant long-term environmental issues and waste buildup.  the project has fast-tracked the development of low-cost technologies for separating layers (delamination) and reviving usable components (regeneration) – all on an industrial scale Dr Jacqueline Edge from the Department of Mechanical Engineering She leads the sustainability assessment workstream which includes life cycle assessment and techno-economics and works to develop these metrics for the direct recycling processes being developed within the project Dr Evangelos Kallitsis is a postdoctoral researcher within the project developing models to analyse the environmental impact of direct recycling processes and position them in a broader context of establishing a sustainable lithium-ion battery value chain Dr Edge said: “The ReLiB project is pioneering not only novel methods for recovering a wide range of materials from batteries but also assessing the wider impacts of these methods so that we can select the most effective processes from the environmental and economic points of view.” Article text (excluding photos or graphics) © Imperial College London Photos and graphics subject to third party copyright used with permission or © Imperial College London Your contact details will never be published Create your free account to receive personalised content alerts and Re:action our weekly newsletter of the top chemical science stories handpicked from a range of magazines journals and websites alongside insight and analysis from our expert editorial team Tell us what you think. Take part in our reader survey By 2015-05-28T00:00:00+01:00 Peter Atkins was awarded the 1969 Meldola medal for his work in theoretical chemistry The Meldola Medal for 1969 has been awarded to Peter William Atkins in recognition of his work in theoretical chemistry with special reference to the theory of magnetic relaxation and of optical birefringence phenomena Atkins worked for his PhD at Leicester with Professor M C R Symons on the application of electron spin resonance to the study of the structure of inorganic radicals In 1964 he was awarded a Harkness Fellowship for postdoctoral work with Professor D Kivelson at the University of California and began to study magnetic relaxation phenomena In 1965 he returned to England as Fellow of Lincoln College Oxford and university lecturer in the Physical Chemistry Laboratory In 2008 the Meldola Medal  was joined with the Edward Harrison Memorial Prize to form a new prize called the Harrison-Meldola Memorial Prize Peter Atkins went on to write several well known chemistry textbooks that are widely used by students as well as popular science titles including Atkins’ Molecules and Galileo’s Finger: The Ten Great Ideas of Science Site powered by Webvision Cloud Felice Torrisi and Nicola Gasparini have won accolades in this year’s RSC prizes this year has been a record-breaking one for Imperial - with three of the 10 being members of the CPE Dr Nicola Gasparini, from the Department of Chemistry, has won the Materials Chemistry Early Career Prize for his work in understanding processes in materials for advanced solar cells and light detectors These technologies are essential in society for cost-effective, reliable, durable, and efficient devices and for more sustainable energy generation solutions that can replace Dr Felice Torrisi, from the Department of Chemistry, has won a Harrison-Meldola Early Career Prize for innovative contributions to the understanding of charge transport in networks of two-dimensional materials to develop printed electronics Professor Jenny Nelson, from the Department of Physics, has won the Faraday Lectureship Prize for contributions to the understanding and development of novel electronic materials for solar energy conversion She investigates new materials for solar energy conversion, including taking inspiration from nature The note from the Municipality, drawn up on the sidelines of the meeting in the Town Hall, concludes with best wishes for 2024: "Marco still has a long way to go; what he has accomplished is only the beginning of a tiring journey, made up of commitment, training , of sacrifices but also of great and beautiful satisfactions". Dr Powner was awarded the prize for his pioneering investigations into prebiotic synthesis which illuminate key conceptual steps in the origin of life He and his team are seeking to explain the chemical origins of life by reconstructing the chemical pathways physicochemical processes and reaction networks that could have given rise to life on the early Earth Dr Powner said: “I feel honoured to receive the RSC Harrison-Meldola Memorial Prize and acknowledge all of my fantastic co-workers and collaborators at UCL and beyond I was also pleased to discover the parallels between my own scientific interests and those of our closest collaborators with the scientific interests of Raphael Meldola who was Professor of Organic Chemistry at the University of London with research interests extended from evolution to astronomy.” was recognised for her outstanding contributions to the synthesis of inorganic CVD precursors for the development of superhydrophobic paint and non-slip flooring Professor Carmalt's research is focused on the development of a robust water repellent material that can be combined with different adhesives to create “self-cleaning” surfaces – with water droplets able to roll over the surface The material addresses one of the biggest challenges for the widespread application of self-cleaning surfaces by finding a way to make them tough enough to withstand everyday damage Professor Carmalt said: “I was delighted to find out that I had been awarded the 2019 Applied Inorganic Chemistry Award Research in my group over the years has focused on developing new materials and investigating how best to use them to improve our daily lives This award for industrially focused research is great recognition of the hard work not just from me but from my team and collaborators.” chief executive of the Royal Society of Chemistry our lives have been significantly improved by the chemical sciences from medicines and food to the environment itself We are proud of the contribution the chemical sciences make to our global community which is why it is right for us to recognise important innovations and expertise such as these “Our prizes and awards recognise people from a range of different specialisms Every winner is an inspiration to the chemistry community and will play an incredibly important role in enriching people’s lives for generations to come.” The Royal Society of Chemistry’s Awards and Prizes are awarded in recognition of originality and impact of research or for each winner’s contribution to the chemical sciences The Harrison-Meldola Memorial Prize comes with a medal and £5,000 while the Applied Inorganic Chemistry Award comes with a medal and £2,000 Of those to have won a Royal Society of Chemistry Award including 2016 Nobel laureates Jean-Pierre Sauvage Royal Society of Chemistry Professor Claire Carmalt and Dr Matthew Powner Email: m.greaves [at] ucl.ac.uk This website is using a security service to protect itself from online attacks The action you just performed triggered the security solution There are several actions that could trigger this block including submitting a certain word or phrase You can email the site owner to let them know you were blocked Please include what you were doing when this page came up and the Cloudflare Ray ID found at the bottom of this page The Royal Society is a self-governing Fellowship made up of many of the world’s most eminent scientists scientific meetings and exhibitions held by the Royal Society as well as access to videos of past events and information on our venue Discover new research from across the sciences in our international Find out more about our values as a not-for-profit society publisher our support for open science and our commitment to research integrity Find out about our work in areas of current topical interest to the Royal Society The Royal Society provides a range of grant schemes to support the UK scientific community and foster collaboration between UK based and overseas scientists awards and prize lectures recognise excellence in science and technology Explore the latest work from the Royal Society from news stories and blog posts to policy statements and projects You can also find resources for teachers and history of science researchers As a new cataloguer at the Royal Society, I’m relishing the opportunity to handle some wonderful and historically significant records within the collections. At first glance, the Society’s New Letter Books (October 1885-September 1931) may not seem quite as engrossing as provide a fascinating insight into the day-to-day functioning of the Society all those years ago The majority of subjects covered within the letters are administrative in nature; however there are a number of outgoing requests made within the volume I’m currently working through (number 52 1915-16) that feel quite removed from the rest letters asking one Fellow to write an obituary notice for another are common as are messages of sympathy sent out to families of deceased Fellows At the turn of 1916, I noticed an increase in references made to chemists and the chemical industry. The earliest to catch my attention were letters sent to Fellows of the Society, informing them that the President, J J Thomson (1856-1940) was creating an advisory committee to deal with cases that fell under the ‘recent regulation of the Board of Trade’ on analytical chemists I took to the Minutes of Council from 1915-16 to establish what this regulation was consulting and research chemists are not allowed to be called up for service with the Colours without consent of the Royal Society’ [16 January 1916] I was curious to know why such extreme measures were necessary presented a memorial to Council in which a ‘failure to realise that modern industry must be based on scientific research’ was blamed for preventing the British chemical industry from developing as it should The memorial lamented the current ‘backwardness’ in this field and the fact that Britain had allowed foreign rivals to ‘outstrip our own’ It was obvious from very early on in the war that German chemical industries were ahead of those in Britain Germany was quick to exploit the potential of synthetic organic chemistry and by the time the war started it dominated the world market in the production of organic chemical products Maull & Fox 19th century photograph © The Royal Society Another Fellow of the Royal Society to express frustration at this was William Perkin Jr (1860-1929): ‘It is surely remarkable that the study of so important a subject as organic chemistry should not only have been practically ignored by our universities in the past but that even at the present day it does not flourish in the way it does in almost every university and technical school in Germany.’ A letter sent to the Society from Bernard Dyer Dr Dyer notes the longstanding issue that ‘the profession is numerically a small one’ and calls for something to be done promptly in order to address this ‘most serious question’ Britain’s struggle to match Germany’s industrial prowess during the war brought the inherent failings of the British chemical industry to the fore Perkin and Dyer would likely suggest that this was not simply a war-induced phenomenon; their comments point towards a longstanding refusal to take the work of chemists seriously The war simply held a spotlight to this issue this spotlight illuminated the way for more enlightened ideas and by 1919 many had noticed a transformation in the chemical industry To say that the chemical Fellows’ call for chemists to be protected by the Reserved Occupations Regulations was responsible for this transformation might be to stretch the truth but their pressing for a reserve of chemists at the home front no doubt played a part enabling chemical research to develop within those years That the input of the Society’s Fellows in this issue was flagged up to me by one of our New Letter Books makes clear their value as a historical resource the prospect of what lies ahead is an exciting one The Royal Society Library is contributing to a new cataloguing project which brings together… The Royal Society archives hold the notebooks of Sir Robert Wilson FRS Article on the invention of the stereoscope and the rival claims of two Royal Society Fellows,… we can benefit humanity and tackle the biggest challenges of our time Subscribe to our newsletters to be updated with the latest news on innovation The Royal Society is a Fellowship of many of the world's most eminent scientists and is the oldest scientific academy in continuous existence If you want to change font size or background color,please turn on Javascript December 4, 2023in Japanese a delegation of medical professionals from Sant'Orsola Malpigi Hospital both certified as IRCCS* oncology research centers Hitomi Okuma of the Department of International Clinical Development gave an overview of NCC Hospital and clinical research Assistant Chief of the Department of Hepatobiliary and Pancreatic Oncology introduced ongoing HPB clinical research projects Masaru Katoh of the Department of Clinical Genomics NCC Research Institute presented research collaboration projects between Italy and Japan.Dr Brandi from the Sant'Orsola Malpigi Hospital asked many questions about clinical research in HBP and rare cancers Dr Ricciardiello introduced Italian and European clinical research perspectives We mutually confirmed our interest in rare cancer research and had a meaningful exchange of ideas for future research collaboration *IRCCS are recognized for their excellent clinical research and are accredited and funded by the Italian Ministry of Health as ‘Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)’ Sant'Orsola Malpigi Hospital attained oncology IRCCS accreditation in 2021 Sant’Orsola Malpigi Hospital,(back from left) Dr Ricciardiello and Dr Brandi Copyright © National Cancer Center All Rights Reserved Metrics details How to differentiate with MRI-based techniques testicular germ (TGCTs) and testicular non-germ cell tumors (TNGCTs) is still under debate and Radiomics may be the turning key Our purpose is to investigate the performance of MRI-based Radiomics signatures for the preoperative prediction of testicular neoplasm histology differentiating TGCTs and TNGCTs status and (ii) differentiating seminomas (SGCTs) from non-seminomatous (NSGCTs) Forty-two patients with pathology-proven testicular neoplasms and referred for pre-treatment MRI Twelve out of 44 were TNGCTs or other histologies Two radiologists segmented the volume of interest on T2-weighted images Approximately 500 imaging features were extracted Least Absolute Shrinkage and Selection Operator (LASSO) was applied as method for variable selection A linear model and a linear support vector machine (SVM) were trained with selected features to assess discrimination scores for the two endpoints LASSO identified 3 features that were employed to build fivefold validated linear discriminant and linear SVM classifiers for the TGCT-TNGCT endpoint giving an overall accuracy of 89% Four features were employed to build another SVM for the SGCT-SNGCT endpoint with an overall accuracy of 86% The data obtained proved that T2-weighted-based Radiomics is a promising tool in the diagnostic workup of testicular neoplasms by discriminating germ cell from non-gem cell tumors developed a radiomic signature to quantitatively discriminate seminomas from non-seminomatous tumors obtaining higher classification rate compared to the other standard MRI-based techniques (e.g this study extends and improves the work of Zhang et al by investigating the diagnostic performance of internally validated radiomic models in characterizing testicular neoplasms and more specifically differentiating between TGCTs and TNGCTs where classification is still under debate MRI and Radiomics together allow accurate characterization of testicular lesions successfully guiding clinical decision-making MR images showing the segmentation process in a 27-year-old man with testicular seminoma (a) and a 31-year-old man with Leydig cell tumor (b) Written informed consent was waived by the Institutional Review Board In (a) we show VD calculated values for TGCT and TNGCT tumor cell cancers. The same applies for VFDI in (b) and in C for SZLGLE. Confusion matrix of the fivefold cross-validated linear SVM trained to discriminate TGCT from TNGCT status with an accuracy of 89% and a TPR of 95% and 75% for TGCT and TNGCT respectively. In (a) we show VD calculated values for SGCT and NSGCT tumor cell cancers. The same applies for AD, Quartile coefficient of dispersion and energy in (b), (c) and (d) respectively. Confusion matrix of the fivefold cross-validated linear SVM trained to discriminate SGCT from NSGCT status with an accuracy of 86% and a TPR of 87% and 86% for SGCT and SNGCT respectively Here we propose two classifiers to discriminate TGCT-TNGCT and SGCT-NSGCT status based on a selection of features fivefold cross validation was employed to avoid overfitting and increase the robustness of the model; unfortunately an internal validation represents a limitation as an external dataset will be required to confirm the results the data supporting the conclusions of this manuscript are available under request Both the models present the limitation of class imbalance being TNGCT and NSGCT the minority classes recall and F1-score (which combines the two previous metrics) was performed for these models we obtained a 0.78 F1-score for NTGCT and 0.85 for NSGCT that are consider a fair level for model reliability we believe that Radiomics can be integrated with other quantitative techniques such as ADC and DCE to improve testicular mass classification accuracy We are aware that another limitation of this study lies in its retrospective nature and in the relatively low number of patients the dependency of the features identified on contouring method and scanner vendors was not explored in this study our preliminary study shows that the radiomic measures obtained by scrotal MR image analysis may be useful in the diagnostic workup of testicular lesions since they could add valuable information and help to discriminate among testicular neoplasms by differentiating germ cell from non-gem cell tumors our conclusion currently should be considered as a proof of concept because further independent validation with an external cohort of patients is required to assess whether other quantitative imaging features may improve the characterization of testicular lesions The datasets considered in this work is available from the corresponding author on reasonable request Image biomarker standardisation initiative Standardized environment for radiomics analysis Volume fraction difference between 10 and 90% Intensity Global trends in testicular cancer incidence and mortality ESMO Consensus conference on testicular germ cell cancer: Diagnosis MRI of the scrotum: Recommendations of the ESUR scrotal and penile imaging working group Sonographically indeterminate scrotal masses: How MRI helps in characterization MRI in the histologic characterization of testicular neoplasms Diffusion-weighted MR imaging of normal and abnormal scrotum: Preliminary results Advantage of adding diffusion weighted imaging to routine MRI examinations in the diagnostics of scrotal lesions Dynamic contrast-enhanced and diffusion-weighted MR imaging in the characterisation of small Radiomics: The facts and the challenges of image analysis T2-Weighted image-based radiomics signature for discriminating between seminomas and nonseminoma Quantitative Nuclear Medicine Imaging Using Advanced Image Reconstruction and Radiomics (Springer Image Biomarker Standardisation Initiative (Springer RStudio: Integrated Development Environment for R Germ cell tumors of the gonads: A selective review emphasizing problems in differential diagnosis Testicular tumors: What radiologists need to know—differential diagnosis EAU Guidelines on Testicular Cancer (Springer Spectrum of extratesticular and testicular pathologic conditions at scrotal MR imaging MR imaging of scrotal tumors and pseudotumors Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology Unresectable pancreatic ductal adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting outcomes of patients treated with chemotherapy Applying radiomics to predict pathology of post chemotherapy retroperitoneal nodal masses in germ cell tumors (GCT) Diffusion-weighted magnetic resonance imaging in the characterization of testicular germ cell neoplasms: Effect of ROI methods on apparent diffusion coefficient values and interobserver variability Apparent diffusion coefficient values and dynamic contrast enhancement patterns in differentiating seminomas from nonseminomatous testicular neoplasms Download references We would like to thank Alessandro Vagheggini for statistical support; Giorgio Mazzotti and Tiziana Licciardello for technical assistance and important discussions on the topic These authors contributed equally: Giacomo Feliciani and Lorenzo Mellini Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS Department of Morphology Surgery and Experimental Medicine Melchiore Giganti & Gian Carlo Parenti interpreted the data and deeply revised the paper performed statistical revision and supervised statistical analysis performed lesion contour and designed the study designed the work and interpreted the data The authors declare no competing interests Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations Download citation DOI: https://doi.org/10.1038/s41598-021-83023-4 Anyone you share the following link with will be able to read this content: a shareable link is not currently available for this article Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research We are proud to announce the 2018 winners of our prizes and awards celebrating the outstanding work happening in every corner of the scientific community Our annual prizes and awards recognise achievements by individuals teams and organisations in advancing the chemical sciences Each year’s winners follow in the footsteps of some of the most influential and inspiring scientists in the world Our chief executive Robert Parker says: “The chemical sciences are vital for the wellbeing of our world and chemical scientists help to change people’s lives for the better That’s why we’re so proud to celebrate the innovation and expertise of our community through our prizes and awards “This year’s inspiring and influential winners come from a range of specialisms Each has done their bit to advance excellence in the chemical sciences – to improve the lives of people around the world now and in the future.” With over 80 prizes and awards in our main portfolio We have categories for both early career researchers and more established researchers – as well as awards aimed specifically at the education sector and at industry The awards also acknowledge the importance of teamwork across the chemical sciences and the abilities of individuals to develop successful collaborations Among this year’s prizes and awards are five aimed specifically at the education sector, and these are covered in more depth in our magazine for chemistry educators, Education in Chemistry excellence and dedication deserve recognition and reward In celebration of our 2018 prizes and awards, we have collected together some of the exciting research recently published by the winners in our journals The collection is free to access for a limited period Across all areas of the Royal Society of Chemistry we are committed to supporting and improving diversity and inclusion Our statistics relating to gender diversity in our prizes and awards programme are published below Prizes and awards statistics – 2018 gender diversity © Royal Society of Chemistry 2025. Registered charity number 207890. We enrolled a preliminary cohort of 9 adult patients (aged >18 years) with a diagnosis of rHGG. HSRT was administered in daily 5-Gy fractions for 3-5 consecutive days a week. Each fraction was delivered up to maximum of 60 minutes after HBO. HSRT delivered after HBO appears to be effective for the treatment of rHGG, it could represent an alternative, with low toxicity, to systemic therapies for patients who cannot or refuse to undergo such treatments. www.ClinicalTrials.gov, identifier NCT 03411408. Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.643469 This article is part of the Research TopicImpact of Radiotherapy and Radiosurgery on Neuro-OncologyView all 10 articles Background: The presence of hypoxic cells in high-grade glioma (HGG) is one of major reasons for failure of local tumour control with radiotherapy (RT) The use of hyperbaric oxygen therapy (HBO) could help to overcome the problem of oxygen deficiency in poorly oxygenated regions of the tumour We propose an innovative approach to improve the efficacy of hypofractionated stereotactic radiotherapy (HSRT) after HBO (HBO-RT) for the treatment of recurrent HGG (rHGG) and herein report the results of an ad interim analysis Methods: We enrolled a preliminary cohort of 9 adult patients (aged >18 years) with a diagnosis of rHGG HSRT was administered in daily 5-Gy fractions for 3-5 consecutive days a week Each fraction was delivered up to maximum of 60 minutes after HBO Results: Median follow-up from re-irradiation was 11.6 months (range: 3.2-11.6 months) The disease control rate (DCR) 3 months after HBO-RT was 55.5% (5 patients) Median progression-free survival (mPFS) for all patients was 5.2 months (95%CI: 1.34-NE) while 3-month and 6-month PFS was 55.5% (95%CI: 20.4-80.4) and 27.7% (95%CI: 4.4-59.1) Median overall survival (mOS) of HBO-RT was 10.7 months (95% CI: 7.7-NE) No acute or late neurologic toxicity >grade (G)2 was observed in 88.88% of patients Conclusions: HSRT delivered after HBO appears to be effective for the treatment of rHGG to systemic therapies for patients who cannot or refuse to undergo such treatments Clinical Trial Registration: www.ClinicalTrials.gov We propose an innovative approach to improve the efficacy of HSRT using image-guided helical TomoTherapy after HBO for the treatment of recurrent HGG (rHGG) Herein we report the results of an ad interim analysis Adult patients (aged >18 years) with rHGG, as defined by RANO (Response Assessment for Neuro-Oncology) criteria (33), underwent HBO followed by re-irradiation (RE-RT). Main inclusion criteria are shown in Table 1 Exclusion criteria were as follows: radiotherapy ≤12 weeks prior to diagnosis of progression if the lesion was in the radiation field; b) cardiopulmonary disease (heart failure chronic obstructive pulmonary disease with hypercapnia sinusitis); and closed-angle glaucoma with ocular pressure >24 mmHg This was a pilot study of Hypofractionated Stereotactic Radiotherapy (HSRT) using TomoTherapy This trial provided 5 Gy/day for 3-5 consecutive days after daily HBO for the treatment of recurrent malignant high-grade glioma(rHGGs) The maximum time from completion of decompression to HRT was 60 min The primary objective of this study was to evaluate the disease control rate (DCR) of treated patients DCR was defined as the percentage of patients with rHGG who have achieved complete response partial response and stable disease 3 months after HBO-RT Secondary objectives were safety assessment (acute and late toxicity) HBO was administrated in a multiplace hyperbaric chamber according to the following schedule: ten min of compression with a fraction of inspired oxygen (FiO2) >90% from 152 to 253 kilopascal 60 min of FiO2 >90% at 253 kilopascal (three breathing cycles in oxygen of 22 min each with 2-minute intervals breathing air and 10 min of decompression with a FiO2 >90% from 253 to 152 kilopascal Computed tomography (CT) planning (Brilliance Big Bore CT Philips UK) was performed with a 1- to 3-mm slice thickness Patients were placed in a supine position with arms close to their body and immobilized with a thermoplastic mask A co-registration of volumetric CT and magnetic resonance imaging (MRI) sequences (1- to 3-mm slice thickness) was performed to define the targets and organs-at-risk (OAR) MRI sequences were performed using a 1.5-T with T1-weighted imaging contrast-enhanced T1-weighted axial imaging with gadolinium (Gd-MRI) fluid-attenuated inversion recovery imaging (FLAIR) dynamic susceptibility contrast-enhanced (DSC) and dynamic contrast-enhanced (DCE) perfusion The planning treatment volume 1 (PTV1) was defined as the visible tumour on enhanced T1-MRI with a 1-mm margin expansion In accordance with the neuroradiology team another treatment volume (PTV FLAIR) was delineated to include the surrounding edema in cases where non-enhanced areas highlighted by increased T2-weighted FLAIR signal were evaluated as disease progression In patients in whom PTV FLAIR was delineated, a total dose of 12 and 20 Gy was delivered (99% isodose line covering 99% of the PTV); 15 Gy and 25 Gy were prescribed to the PTV1 in 3-5 daily fractions at the isodose of 67% (Figure 1) The treatment dose was chosen on the basis of the Karnofsky Performance Status (KPS) of the patient the interval between the first and second radiotherapy course and the proximity of critical organs to the targets All patients underwent image-guided helical TomoTherapy (HT) (TomoTherapy Inc. The HT system uses image-guided RT in which a CT scan is performed before each treatment allowing the radiotherapist to verify and adjust the patient’s position as needed to ensure that the radiation is directed exactly at the target area Figure 1 Examples of (A) dose distribution and (B) typical dose volume histogram (DVH) for a prescription dose of 15 Gy in 3 fractions to PTV1 and 12 Gy in 3 fractions to PTV FLAIR Simon’s two-stage design was used to estimate sample size (35) If there were 3 or fewer DCRs in these 9 patients 15 additional patients would be accrued for a total of 24 The null hypothesis would be rejected if 13 or more patients with DCR were observed in 24 patients This design yielded a type I error rate of 0.05 and power of 80% for a true DCR of 0.62 The percentage of patients who achieved complete response partial response and stable disease were calculated to evaluate the primary endpoint and 95% confidence intervals (95%CI) were derived from the exact binominal distribution the number and percentage of treated patients experiencing grades 1-4 adverse events were tabulated OS and PFS were estimated with the Kaplan-Meier Method (two-sided 95%CI) and the role of potential stratification factors was analysed with the log-rank test All 9 patients completed RE-RT after HBO without interruption. Five patients underwent HBO-RT treatment over 3 consecutive days and the remaining four over 5 days (Figure 1). Details of the RT planning are reported in Table 3 The median time between HBO and the radiotherapy fraction was 24 minutes (04-50 minutes) Median follow-up from RE-RT was 11.6 months (range 3.2-11.6 months). No patient was lost to follow-up. Three months after treatment, 5 patients (55.5%) maintained local disease control, while 4 showed progression and the accrual of the first stage of the two-stage design was completed. Median progression-free survival (mPFS) for all patients was 5.2 months (95%CI: 1.34-NE) (Figure 2) 2 patients underwent treatment with temozolomide one with fotemustine and one with PCV (procarbazine Figure 2 Progression-free survival (PFS) after HBO-RT Median overall survival (mOS) of HBO-RT was 10.7 months (95% CI: 7.7-NE) (Figure 3) 5 patients with recurrent GBM (rGBM) had died (disease progression) and 4 were still alive all living virtually normal daily lives until PD a 60-year-old woman obtained local disease control (3 months after HBO-RT); a 36-year-old man with recurrent GBM developed PD 12 months after completing HBO-RT and underwent treatment with bevacizumab; one patient with recurrent anaplastic oligodendroglioma progressed after 6 months; and one patient with recurrent AA progressed after 3months Neurocognitive functions remained stable until PD MMSE values for each patient were stable until PD Figure 3 Overall survival (OS) after HBO-RT No patients had convulsive seizures during or after HBO All patients completed treatment without interruption During treatment dexamethasone ≥2 mg was administered to all patients Three months after HBO-RT treatment Three patients continued with 2 mg dexamethasone while two took 4 mg dexamethasone and one 8 mg and three none No acute or late neurologic toxicity >grade 2 (CTCAE version 4.3) was observed in 8 patients A 71-year-old man with rGBM showed symptoms and radiological signs of grade 3 radionecrosis the patient had GBM with unmethylated MGMT He underwent re-irradiation 24 months after postoperative RT with a total dose of 25 Gy in 5 fractions to PTV1 (volume 0.96 cc) and 20 Gy in 5 sessions to PTV FLAIR (volume 34.94 cc) DSC and DCE perfusion MRI revealed a suspicion of radionecrosis and concomitant O-(2-[18F]fluoroethyl-)-L-tyrosine (18F-FET) PET/CT was performed to support the differential diagnosis of PD or treatment-related changes The patient was treated successfully with corticosteroids and bevacizumab The present paper reports the results of the first phase of a clinical trial conducted according to a Simon’s two-stage design to evaluate whether re-irradiation of rHGG after HBO can improve the efficacy of RT They confirmed a survival benefit from this treatment Table 4 Studies on HSRT for recurrent high-grade glioma The BED10 calculated for 25 Gy in 5 fractions was 37.50 Gy10 In a recent multicentre study on re-irradiation of recurrent glioma, Navarria et al. identified a BED10 threshold of >43 Gy that influenced survival (60) Although our calculated BED is lower than that of other series our patients showed similar outcomes to those of other studies Our ad interim analysis thus suggests a possible advantage of adding HBO to HSRT for the local control of rHGG Bennet et al. suggested that the dose per fraction may influence the importance of the benefit derived from hypoxic modification. They concluded that the use of hypofractionation results in a more pronounced modification of hypoxia (43) hypofractionation delivered by image-guided helical TomoTherapy which enables large tumour volumes to be treated minimizing the toxicity associated with high dose fractionation Our analysis ad interim showed only one case of radionecrosis grade 3 CTCAE Although the results from the present study suggest that the use of RT after HBO is a safe and practical procedure our preliminary findings must obviously be interpreted with caution because of the small number and inhomogeneity of the patients involved We thus aim to validate the results in the second part of the study in which another 15 patients will be recruited One of advantages of HBO- RT is the reduced overall treatment time (3-5 consecutive days) Further randomized studies in primary and recurrent settings are needed to confirm our findings The original contributions presented in the study are included in the article/Supplementary Material Further inquiries can be directed to the corresponding author The studies involving human participants were reviewed and approved by IRCCS IRST Ethics Committee The patients/participants provided their written informed consent to participate in this study and PC conceived the idea for and designed the study and AS collected and assembled the study data AR and GM revised the manuscript for important intellectual content All authors contributed to the article and approved the submitted version The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest The authors thank Gráinne Tierney for editorial assistance The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fonc.2021.643469/full#supplementary-material dynamic susceptibility contrast-enhanced; DSC dynamic susceptibility contrast-enhanced; DWI fluid-attenuated inversion recovery imaging; Gd-MRI hypofractionated stereotactic radiotherapy; HSRT hypofractionated stereotactic radiotherapy; HT mini-mental state examination; mOS median overall survival; mPFS response assessment for neuro-oncology; RE-RT Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Therapeutic options for recurrent malignant glioma Lomustine and Bevacizumab in Progressive Glioblastoma Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): A randomised controlled phase 2 trial Effect of Nivolumab vs Bevacizumab in Patients with Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report Therapeutic options in recurrent glioblastoma–An update Crit Rev Oncol Hematol (2016) 99:389–408 doi: 10.1016/j.critrevonc.2016.01.018 Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures PubMed Abstract | CrossRef Full Text | Google Scholar Expression of hypoxia inducible factor-1α in tumors of patients with glioblastoma multiforme and transitional meningioma Angiogenesis in Gliomas: Biology and Molecular Pathophysiology doi: 10.1111/j.1750-3639.2005.tb00115.x CrossRef Full Text | Google Scholar PubMed Abstract | CrossRef Full Text | Google Scholar Biology of Angiogenesis and Invasion in Glioma PubMed Abstract | CrossRef Full Text | Google Scholar Anti-invasive and antiangiogenic effects of MMI-166 on malignant glioma cells Inhibition of angiogenesis and invasion in malignant gliomas Expert Rev Anticancer Ther (2007) 7:1537–60 The interactions of polarographic measurements of oxygen tension and histological grade in human glioma doi: 10.1097/00130404-200611000-00005 Change of oxygen pressure in glioblastoma tissue under various conditions Intratumoral oxygen pressure in malignant brain tumor Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue Potential roles of hyperbaric oxygenation in the treatments of brain tumors Undersea Hyperb Med (2013) 40:351–62 PubMed Abstract | Google Scholar Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies Hyperbaric oxygen therapy and cancer - A review PubMed Abstract | CrossRef Full Text | Google Scholar Hyperbaric oxygen therapy for late radiation tissue injury Cochrane Database Syst Rev (2016) 4:CD005005 Hyperbaric oxygenation for tumour sensitisation to radiotherapy Cochrane Database Syst Rev (2012) 5:CD005005 CrossRef Full Text | Google Scholar Hyperbaric oxygen therapy as adjunctive strategy in treatment of glioblastoma multiforme Radiotherapy after hyperbaric oxygenation improves radioresponse in experimental tumor models Preservation of tumour oxygen after hyperbaric oxygenation monitored by magnetic resonance imaging Measurement of regional cerebral blood flow oxygen extraction ratio and oxygen utilization in stroke patients using positron emission tomography Exp Brain Res (1982) Suppl 5:182–86 Metabolic and hemodynamic evaluation of gliomas using positron emission tomography PubMed Abstract | Google Scholar Radiotherapy after hyperbaric oxygenation in malignant gliomas Curr Med Res Opin (2015) 31:1977–84 Old but new methods in radiation oncology: Hyperbaric oxygen therapy Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas Updated response assessment criteria for high-grade gliomas: Response assessment in neuro-oncology working group 34. Cancer Institute N. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 (2009). Available at: http://www.meddramsso.com (Accessed May 23 Google Scholar Optimal Two-Stage Designs for Phase II Clinical Trials PubMed Abstract | CrossRef Full Text | Google Scholar Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS Consortium phase I and II clinical trials Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide Appraisal of re-irradiation for the recurrent glioblastoma in the era of MGMT promotor methylation PubMed Abstract | CrossRef Full Text | Google Scholar Re-irradiation for recurrent high-grade gliomas: A systematic review and analysis of treatment technique with respect to survival and risk of radionecrosis The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck - A systematic review and meta-analysis The impact of hypoxia and its modification of the outcome of radiotherapy J Radiat Res (2016) 57 Suppl 1:i90–8 PubMed Abstract | CrossRef Full Text | Google Scholar CrossRef Full Text | Google Scholar QJM - Mon J Assoc Physicians (2004) 97:385–95 CrossRef Full Text | Google Scholar Hyperbaric oxygen and malignancies: a potential role in radiotherapy Med Sci Monit (2005) 11(9):RA279–89 Google Scholar A phase II study of radiotherapy after hyperbaric oxygenation combined with interferon-beta and nimustine hydrochloride to treat supratentorial malignant gliomas Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine and vincristine) for high-grade gliomas: Long-term results Int J Radiat Oncol Biol Phys (2012) 82:732–8 Effects of radiotherapy after hyperbaric oxygenation on malignant gliomas Radiotherapy using IMRT boosts after hyperbaric oxygen therapy with chemotherapy for glioblastoma Hypofractionated stereotactic re-irradiation: Treatment option in recurrent malignant glioma Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma Hypofractionated Stereotactic Reirradiation of Recurrent Glioblastomas Strahlentherapie und Onkol (2009) 185:235–40 CrossRef Full Text | Google Scholar Treatment of recurrent high grade gliomas with hypofractionated stereotactic image-guided helical tomotherapy Clin Neurol Neurosurg (2011) 113:509–12 Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas Patterns of Failure After Concurrent Bevacizumab and Hypofractionated Stereotactic Radiation Therapy for Recurrent High-Grade Glioma Int J Radiat Oncol (2013) 85:636–42 Hypofractionated stereotactic reirradiation for recurrent glioblastoma J Neurooncol (2014) 120:117–23 Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score—report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK) Re-irradiation for recurrent glioma: outcome evaluation toxicity and prognostic factors assessment A multicenter study of the Radiation Oncology Italian Association (AIRO) Re-irradiation of recurrent glioblastoma using helical TomoTherapy with simultaneous integrated boost: preliminary considerations of treatment efficacy Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survival hypofractionated stereotactic radiotherapy Martinelli G and Romeo A (2021) Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma Received: 18 December 2020; Accepted: 09 March 2021;Published: 30 March 2021 Copyright © 2021 Arpa, Parisi, Ghigi, Cortesi, Longobardi, Cenni, Pieri, Tontini, Neri, Micheletti, Ghetti, Monti, Foca, Tesei, Arienti, Sarnelli, Martinelli and Romeo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) distribution or reproduction in other forums is permitted provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited in accordance with accepted academic practice distribution or reproduction is permitted which does not comply with these terms *Correspondence: Donatella Arpa, ZG9uYXRlbGxhLmFycGFAaXJzdC5lbXIuaXQ= Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher 94% of researchers rate our articles as excellent or goodLearn more about the work of our research integrity team to safeguard the quality of each article we publish Sponsored by 2020-09-08T13:42:00+01:00 An accomplished lineup of speakers will present at the New frontiers in synthetic chemistry conference co-hosted by AstraZeneca and the Royal Society of Chemistry in November Following the success of 2019’s inaugural conference at Burlington House in London this year’s virtual event aims to unite scientists with an interest in chemical synthesis under an industry–academia collaboration umbrella attendees at all career levels can explore innovation in molecular discovery creative catalysis techniques and organic synthesis in general Source: Phil Rowley/University of Nottingham who won the Harrison-Meldola Memorial Prize while working at the University of Nottingham will speak at the conference about biocatalytic chemistry Royal Society of Chemistry (RSC) Harrison-Meldola memorial prize winner Elaine O’Reilly is an associate professor of chemical biology at University College Dublin She began her independent research career at Manchester Metropolitan University before becoming an assistant professor of chemical biology at the University of Nottingham in 2015 she experimented with transaminase reactions using engineered bacteria that enabled the reactions to be performed in whole cells work that contributed to a paper published in RSC journal Green Chemistry[1] in June The ability to develop designer catalysts with the desired properties is revolutionising chemical synthesis In her presentation Biocatalytic approaches to complex targets O’Reilly will explain how the ‘extraordinary selectivity associated with enzymes coupled with easy access to designer biocatalysts with the desired properties ‘It’s this unrivalled selectivity that makes them extremely attractive catalysts for the synthesis of complex chiral molecules,’ she says ‘The ability of these catalysts to operate under similar reaction conditions also means that it is possible to design multi-enzyme cascade reactions where the product of one biocatalytic step becomes the substrate for the next enzymatic transformation,’ she adds says O’Reilly, can significantly reduce the number of synthetic manipulations It is this cost effectiveness that make the design of such processes attractive to industry O’Reilly’s research group is interested in biocatalysts and biocatalytic methodology that can simplify synthetic routes to high-value targets and overcoming the challenges that hamper the widespread application biocatalysts O’Reilly will explore some of her group’s recent biocatalytic methodology developments ‘The purpose of my presentation will be to demonstrate how enzymes can help simplify synthetic approaches to challenging compounds.’ Allan Watson was recognised for his endeavour to understand the mechanism of catalytic reactions and generate new approaches for making C–X bonds After obtaining his MSc degree and organometallic methodology PhD at the University of Strathclyde Watson moved to study natural product total synthesis at Princeton University in New Jersey Why is the way we access bioconjugate molecules so ineffective for scaled up production Watson has been a reader in homogenous catalysis at the University of St Andrews He leads the Watson Group in solving catalysis problems using mechanism but with a focus on application He is a named author in 64 research papers and has presented at almost as many scientific gatherings since 2011 He presented at the ACS’s 2017 spring meeting in San Francisco and the RSC’s New frontiers in organic chemistry conference in 2016 In his presentation Academic synthesis with applied purpose Watson will reveal some of the molecules his group is making in the lab ‘I will talk about how we are making them and The presentation will also discuss the potential anti-cancer properties of a set of molecules called aspidosperma alkaloids ‘Although the target of many total synthesis efforts over the years there’s little data to explain their properties or structure–activity relationships ‘I will explore the natural molecule coronatine which has been touted as a potential herbicide lead in agrochemical research but no data exists on the origin of its activity,’ Watson adds Bioconjugates are large molecules used in central nervous system therapies and Watson considers them key to chemical biology and drug research are currently not accessed effectively for exploration of biological properties,’ he says and a key question to address is why the way this large molecule is being accessed is so ineffective for scaled up production,’ Watson adds Making molecules for a real world application is key says Allan Watson A transborylation technique that renders stoichiometric organoborane reactions catalytic is the theme of Stephen Thomas’s presentation.Currently a Royal Society University Research Fellow at the University of Edinburgh Thomas gained his MChem at Cardiff University and PhD at the University of Cambridge a Thieme Journal award and a Pfizer green chemistry research award to his name the Thomas Group investigates organometallic catalysis Thomas’s team uses non-precious metals to replace the reactivity of traditionally used second and third row transition metals Turning organoboranes into catalysts – it’s a different take on catalyst turnover In his presentation Catalysis using metalloid hydrides Thomas will show how his group took half-century-old stoichiometric organoboranes and turned them into catalysts. ‘It’s a different take on catalyst turnover,’ says Thomas ‘It means we will finally be solving 50-year-old challenges.’ Stephen Thomas turned 50-year-old reagents into catalysts The philosophy behind Thomas’s approach to catalyst selection is that ‘if you can buy it in a health food store ‘This provides a limit to play within,’ he explains ‘We try to remove the practical challenges of organometallic catalysis with first-row transition metals to make it as easy to use as palladium catalysis.’ the Thomas group has been exploring the use of organoboron catalysts Organoborane use is popular and it was well-used before asymmetric metal catalysis ‘We want to be able to do catalysis with boron – whether asymmetric or not – and we are trying to get the reactivity of transition metal catalysts but using a different turnover mechanism for organoboranes ‘Transborylation essentially relies on ligand exchange and redistribution – it’s about controlling that redistribution so that we can control the rate and selectivity of that process.’ Registration includes access to the virtual conference, attendance at all discussion sessions and entry to networking forums. Tickets are available via the Royal Society of Chemistry website 1. Green Chem., 2020,22, 4128-4132 (DOI:10.1039/D0GC01432J) We use Eventbrite to manage event bookings Eventbrite may store cookies on your device for functional Accept cookiesBook via Eventbrite This content is provided by " + networkList[key] + " If you view or interact with this content " + networkList[key] + " may store cookies on your device for functional By 2006-09-01T00:00:00+01:00 teenage chemistry student William Henry Perkin synthesised a purple dye from coal tar the inconvenient waste of the burgeoning coal-gas industry.1 One hundred and fifty years on has the significance of this discovery been forgotten The young William Henry Perkin (1838-1907) at the Royal College of Chemistry in London.2 Head of the college at that time was the German chemist August Wilhelm Hofmann renowned for his research into the aromatic amine which was used to describe the constituents of chemical compounds in the days before structural theories became available.   Hofmann was investigating ways of transforming coal tar into useful products working in his home laboratory during Easter of 1856 was trying to synthesise quinine via condensation of two molecules of allyltoluidine he wisely decided to repeat the experiment with the simplest aromatic amine afforded a purple solution that dyed a piece of silk a brilliant purple.3 printers and dyers in the textile producing regions of Lancashire and Scotland filed a patent for his process: the conversion of benzene into nitrobenzene and oxidation to afford a mixture that included a few per cent of the novel dye or Tyrian purple as it was originally called To encourage textile dyers to buy his aniline dye Perkin devised a way to attach the dye to cotton fabrics by using tannic acid.   The dyers were reluctant to change from the traditional natural dyes until the synthetic colorant was adopted in France late in 1858 So while Perkin's manufacturing process and the method of application were together a triumph of methodology based on observation and a keen insight in one so young the dye succeeded commercially only because the colour purple was all the rage among the fashionable ladies of Paris from the French word for the mallow flower though in 1863 Perkin gave his dye a more scientific name the structure of mauveine was established only in 1993 by O And thus the high-street rage for mauve started the modern organic chemical industry which was based on aromatic intermediates derived from coal-tar hydrocarbons.5 The second important synthetic dye to come on the market was a red The dye was formed only because aniline contained significant amounts of the aromatic amines o- and p-toluidine a blue aryl derivative of the red was synthesised Hofmann speculated correctly that alkyl derivatives would afford violets.6 From Perkin's discovery there arose not only dyestuffs as well as the first industrial research laboratories Carl Liebermann and Heinrich Caro independently discovered routes to synthetic alizarin the important red colorant in the root of the madder plant whose large-scale cultivation soon after ceased.   through mastery of organic chemistry based on Kekulé's benzene ring theory and superior research and marketing organisations the dyes industry passed to Germany.7 By 1897 the Germans had taken over leadership from the UK's industry and were manufacturing synthetic indigo by one of two routes starting with either benzene or naphthalene (In 1883 Adolf Baeyer wrote the first almost correct structure for indigo in a letter to his industrial collaborator and in 1905 received the Nobel prize for chemistry in part for this work.)8 German synthetic indigo destroyed the British monopoly on the main agricultural export - Indigofera tinctoria - of colonial India British and Indian scientists tried to improve the yield of the natural product but their endeavours did contribute to the development of science in India.  In recognition that Perkin's discovery inaugurated the world's first hi-tech industry - the modern organic chemicals industry - there were various jubilee (1906) and centenary (1956) celebrations around the world the Manchester Courier advised its readers that:   if Germany is now reaping most of the gain the development of the coal tar colour industry It is now one of the greatest branches of chemical manufacture.9 This statement accompanied the announcement that British chemists and industrialists were about to convene in London to arrange an international celebration to mark the 1856 discovery of the first synthetic was co-organiser with Professor Raphael Meldola of the 1906 jubilee events for mauve in London all three had worked at the London dye-making firm of Brooke Simpson & Spiller that went bankrupt just before the anniversary The inventions of Meldola and Green were not fully appreciated by the management and Meldola's blue and Green's primuline were copied by the Germans to their commercial advantage This was a hard-earned lesson for the British Great inventiveness if not properly controlled or developed was soon applied elsewhere.   Meldola realised what was happening soon after leaving the dyes industry in 1885 On the basis of his own experience and the results of enquiries among textile dyers and printers Meldola lobbied for improved scientific education to reverse the loss of the world's first science-based industry.  decline followed lack of interest in the benzene ring theory a slow response to the reform of patent law and failure to do research by teams of scientists based in dedicated industrial research laboratories Despite lectures before the Royal Society of Arts Science teaching and technical education remained in the doldrums Britain preferred to rely on profits from its colonial enterprises rather than on a science-based industry.  Fortunately Meldola was a spokesman for science with influential friends who supported the 50th anniversary events the 1906 jubilee was a celebration of rational human achievement He was not about to let the matter of loss of British inventiveness spoil the proceedings Diplomacy drove his speeches at the Royal Institution and a grand dinner in July 1906 events attended by the then ageing and newly knighted Sir William Henry Perkin a modest man of strong religious convictions who had given generously to Christian charities Before British and foreign dignitaries and leaders of science and industry 'to enter into the vexed question of causes' for loss of the dye industry from Britain.   It took until 1914 before Meldola's warnings were heeded With the outbreak of World War I in Europe the dyes industry - the principal producer of aromatic nitro compounds used in the manufacture of explosives and coal tar-derived medicinal products for treating the wounded - suddenly became a strategic industry The problem for Britain was that the country had become dependent on Germany for the supply of many essential aromatic organic chemicals.   Revival of the ailing dye industry became a matter of urgency Meldola was co-opted onto government commissions and devoted his energies to the war effort He was appointed a member of the Board of Trade Committee on the Supply of Chemical Products and in 1915 chairman of the advisory council of British Dyes and of the forerunner of the Department of Scientific and Industrial Research To commemorate the 150th anniversary of William Perkin's discovery of the first synthetic dye the Royal Society of Chemistry (RSC) is holding a number of events the British dyes industry became the first nationalised industry British Dyes was expanded to form the British Dyestuffs Corporation which from 1925 became a major part of Imperial Chemical Industries (ICI) Other nations also began to nurture their dyes industries The entry into dyes manufacture forced American firms to adopt new strategies based on the German model including the opening of industrial research laboratories and an emphasis at universities on complex organic chemistry This led to successes such as novel polymers a range of sulfa drugs that were invaluable during World War II.   the US synthetic dyes industry was the world leader which is why the week-long New York celebrations for the 100th anniversary of the founding of the coal tar dyes industry were the grandest ICI announced the first of the fibre reactive (Procion) dyes that form a chemical bond with the fibre.   The 1960s' Kennedy round of trade negotiations which led to massive import of textiles into the US caused the US dyes industry to decline from around 1980.10 The Europeans followed suit a decade later.   there will be little in the way of celebration to mark the 150th anniversary of the discovery of mauve from events organised by the Royal Society of Chemistry (RSC) The reasons are partly to do with current perceptions of the dye-making industry: polluting and hardly practised any more in Europe and North America The great European dye-makers of the past have moved on to research and development in the life sciences and many have changed their corporate names - that sometimes included the word aniline (such as AGFA and BASF) - in the process Perkin's work should be celebrated as an inspiration for young aspiring chemists And it is worth taking a moment to consider where one of our greatest preoccupations president of the Chemical Society during 1905-07 was a charismatic man whose interests went far beyond chemistry Grandson of the chief rabbi of London's Sephardic Jewish community successor to the Royal College of Chemistry he later undertook spectrum analysis for Edward Frankland at the Royal College of Science Following Frankland's recommendation to the astronomer Joseph Norman Lockyer Meldola was placed in charge of the instruments and chemicals required to photograph the total eclipse of the Sun from the Nicobar Islands the venture failed at the critical moment - heavy clouds masked the Sun and promoted investigations into ancient earthworks particularly as a prominent member of the Essex Field Club became a member of the Royal Society on the basis of his contributions to biology he was a keen evolutionist who kept his wife and mother busy during holidays and trips by encouraging them to collect moths.   Meldola was a capable chemist who worked for a number of years in the British dyes industry His first foray into industry (1871-73) was at a firm in West London that later employed Otto Witt who suggested a theory of colour and constitution and placed colour by design on a firm footing after successfully predicting a then unknown azo dye The orange dye was introduced by Heinrich Caro at BASF as chrysoidine.   Meldola encountered a serious problem with his second employer was not interested in filing patents on new inventions that Meldola had made Disappointed by this cavalier attitude towards discoveries In 1885 he was appointed director of the Finsbury Technical College a junior institution of what later became Imperial College of Science and Technology.  Congratulations to Dr Matthew Fuchter who received who received the Royal Society of Chemistry's Harrison-Meldola Memorial Prize for 2014 The Royal Society of Chemistry awarded Dr Matthew Fuchter with the Harrison-Meldola Memorial Prize for 2014 for his contribution to the study of epigenetic processes in disease and his insights into chiral aromatic compounds particularly those with helical chirality Please see here for the full story By 2012-11-29T00:00:00+00:00 The 1976 Meldola medal and prize is awarded The 1976 Meldola medal and prize has been awarded (jointly with Jeremy Burdett) to Martyn Poliakoff for his work in physical organic chemistry with particular reference to the study of matrix isolation and photochemical studies Poliakoff obtained his BA at King’s College working with J J Turner on matrix isolation of large molecules When Turner moved to a chair in Newcastle upon Tyne Poliakoff moved with him to continue his work on transition metal carbonyls Poliakoff started a close collaboration with Jeremy Burdett His current research involves infrared laser-induced reactions and organic and organometallic photochemistry Poliakoff moved from Newcastle to the University of Nottingham where he is currently a research professor Poliakoff’s recent research has focused on supercritical fluids continuous reactions and their applications to green chemistry Dr Clementine Chambon at the unveiling of a new mini solar grid in India Three Imperial academics have won prizes in this year’s Royal Society of Chemistry Awards including Chemistry World Entrepreneur of the Year The academics scooping prizes are Dr Kim Jelfs whose work involves supramolecular materials whose company Oorja provides cheap electricity to rural India who works with conductive molecules and inorganic electronic materials Dr Robert Parker, chief executive of the Royal Society of Chemistry (RSC) said: “The chemical sciences are vital for the wellbeing of our world and chemical scientists help to change people’s lives for the better That’s why we’re so proud to celebrate the innovation and expertise of our community through our Prizes and Awards “This year’s inspiring and influential winners come from a range of specialisms Each has done their bit to advance excellence in the chemical sciences – to improve the lives of people around the world now and in the future.” The Harrison-Meldola Memorial Prizes are awarded for the most meritorious and promising original investigations in chemistry and published results of those investigations receives her prize for ‘her innovative approach to the computer-guided discovery of supramolecular and porous materials’ Dr Jelfs’ work focuses on computer simulations that help predict which materials made of many molecules are the most promising to produce These ‘supramolecular’ materials have applications in electronics such as materials for solar cells or to generate renewable energy They can also be used in membranes as ‘sieves’ to help separate molecules of different sizes or shapes She said: “I am thrilled to have been awarded a 2018 Harrison-Meldola Memorial Prize This is recognition of the hard work that my research group have been putting in towards developing computational approaches for discovering supramolecular materials and also to the great ongoing collaborations we have with many experimental researchers.” The Chemistry World Entrepreneur of the Year was awarded to Dr Chambon for ‘outstanding contributions to the entrepreneurial application of bioenergy to solving major environmental social and gender challenges in rural India’ Dr Chambon, from the Department of Chemical Engineering, is the cofounder and chief technology officer of Oorja a social enterprise that designs and installs solar and biomass mini-grids reliable electricity to off-grid communities in India By providing a round-the-clock reliable energy supply the company is improving the lives of India’s rural poor enabling them to run equipment and machinery more cheaply leading to a significant increase in their income Their work also has an impact in other areas including economic development Dr Chambon said: “I am very humbled to have been selected to receive the Royal Society of Chemistry’s 2018 Chemistry World Entrepreneur of the Year Award “We are grateful to the Royal Society of Chemistry for recognising our work in delivering affordable and reliable clean energy solutions to underserved communities in India We hope to use this visibility and momentum to accelerate our impact in applying solar and bioenergy to solving major environmental social and gender challenges in rural India.” The Marlow Award is given in recognition of the most meritorious contributions to physical chemistry or chemical physics which rewards him with £3000 to lecture in either Singapore Dr Bakulin’s work focuses on using laser light to investigate the behaviour and functions of conductive molecules and inorganic electronic materials These systems are already used in smartphone displays and may find applications in low-weight and low-cost solar cells as well as next-generation computer technologies He said: “I am delighted and very honoured to receive the Marlow Award from the Royal Society of Chemistry This award acknowledges the highly interdisciplinary science we do in close collaboration with researchers in physics “I want to thank all my collaborators and co-workers who made it possible and I hope that we will keep finding beautiful and practically relevant science in the fields of spectroscopy nanotechnology and plastic electronics.” Five Imperial chemists have been awarded Royal Society of Chemistry Prizes in recognition of the advancements they have made in chemical sciences The Royal Society of Chemistry (RSC) prizes and awards recognise chemical scientists who have made an outstanding contribution in academia Winners are rewarded for their true excellence in shaping the future of the field Of the 60 prizes and awards announced this month five have gone to chemical scientists working at Imperial College London Dr Matthew Fuchter is this year’s Harrison-Meldola Memorial Prize Winner Professor Iain McCulloch has been named the Tilden Prize winner Professor Milo Shaffer and Professor Molly Stevens have received the Corday-Morgan Prize and Dr Edward Tate has received the Norman Heatley Award Dr Matthew Fuchter is a Senior Lecturer in Synthetic and Medicinal Chemistry in the Department of Chemistry He designs new molecules for use in medicine and materials Most recently his group have discovered a new means to eradicate malaria infections by rapidly killing the blood-borne Plasmodium parasites that cause the disease.  Dr Fuchter said: "I am absolutely thrilled to have received the 2014 Harrison-Meldola Memorial Prize I hope to use the associated lectureships to highlight my group's recent exciting and collaborative work concerning function-orientated synthesis." Iain McCulloch is Professor of Polymer Materials in the Department of Chemistry sustainable energy - a key global environmental challenge.  Solar energy is an important potential solution to this challenge but new materials are required in order for this technology to compete with fossil fuels.  Professor McCulloch’s group is currently working towards developing cheaper plastics to create solar panels with much larger areas that are more efficient and more stable under harsh environmental conditions.  Milo Shaffer is Professor of Materials Chemistry in the Department of Chemistry.  His prize is awarded for the most meritorious contributions to chemistry Professor Shaffer works on developing transformative new nanocarbon chemistry and applications that can be applied at a practical scale his research group is currently working on a type of fibre composite found in a tennis racket and A380 jumbo jet to develop new reinforcements that both improve mechanical performance and introduce additional functions Molly Stevens is currently Professor of Biomedical Materials and Regenerative Medicine in the Institute of Biomedical Engineering at Imperial College Her prize is awarded for the most meritorious contributions to chemistry Professor Stevens’ group multidisciplinary group is focused on both high-quality fundamental science and translating science into improvements to human health Her research in regenerative medicine focuses on developing new materials that take inspiration from biology including designing novel bioactive scaffolds and new approaches towards tissue regeneration She has developed novel approaches to tissue engineering that are likely to prove very powerful in the engineering large quantities of human mature bone for transplantation as well as other vital organs such as the liver and pancreas Professor Stevens said: "Winning this award is a real honour and the credit goes in full to the team of fantastic students and postdocs that enable all the research that our group does."  Dr Edward Tate is Reader of Chemical Biology in the Department of Chemistry His award recognises and promotes the importance of multi-disciplinary research between chemistry and the life sciences through independent work Dr Tate develops and applies novel chemistry-based technologies that can help us to understand more about how cells animals and plants function at the molecular level One area that his lab specialises in is identifying and validating drug targets in disease work that goes hand-in-hand with the discovery and development of new drugs for malaria Dr Tate said: "I have been fortunate to work with many amazingly talented research students and postdoctoral researchers and enjoyed highly productive collaborations with outstanding scientists at Imperial The Norman Heatley Award is fantastic recognition for the members of my group who have contributed their great ideas and infectious enthusiasm to advance our research in chemical biology particularly in chemical proteomics and drug target validation." We are proud to announce the 2016 winners of our prizes and awards teams and organisations in advancing the chemical sciences – and rewarding those who undertake excellent work in the chemical sciences across the world There are over 80 prizes and awards available in the main portfolio covering all areas of the chemical sciences An illustrious list of 47 previous winners of the Royal Society of Chemistry’s awards have gone on to win Nobel Prizes for their pioneering work says: "It is an honour to recognise the illustrious achievements of our prize and award winners in our 175th anniversary year "We were founded in 1841 by a group of academics industrialists and doctors who understood the power of the chemical sciences to change our world for the better Our winners share that vision and are advancing excellence in their fields whether through innovative research or inspirational teaching and outreach "We are proud to celebrate and support the work of inspiring and influential individuals whose work has the potential to improve so many lives." Many award categories are evaluated for the originality and impact of their research as well as the quality of the results which can be shown in publications Some awards also recognise the importance of teamwork across the chemical sciences In celebration of our 2016 prizes and awards we have collected together some of the exciting research recently published by the winners in our journals.  The collection is free to access for a limited period totally lost is an open photographic and video research project that discovers surveys and maps abandoned architectural heritage sites linked to the totalitarian regimes of the 20th century in europe video makers and urban explorers are invited to contribute to the evolving documentation of desolate buildings in order to generate discussion and bring attention to the form of each historic structure.  villa girasole, italy image © linthout lorenzo totally lost has involved 186 photographers from all over europe and has mapped almost 300 places linked to totalitarian regimes the project has so far collected over 2,600 photographs of buildings from over 25 nations including; factories the extensive collection will be recognised in an exhibition from the 9th to the 18th and from the 23rd to the 25th of september 2016 in three different locations including; casa del mutilato in forlì forlimpopoli and the casa del fascio di teodorano defenders of stara zagora, bulgaria image © peter franc mine komsomolets gorlivka, ukraine image © gianmatteo cirillo  france image © leonardo crociani  slovakia image © trevor patt  denmark image © michael jödicke hotel igman, bosnia image © anida kreco ‘die verbotene stadt’ military base germany  image © reginald van de velde designboom has received this project from our ‘DIY submissions‘ feature, where we welcome our readers to submit their own work for publication. see more project submissions from our readers here. AXOR presents three bathroom concepts that are not merely places of function but destinations in themselves — sanctuaries of style Scientists working on environmental chemistry membranes and biomedical diagnostics have been honoured with Royal Society of Chemistry's prizes Professor Tony Cass is awarded the Sir George Stokes Award and Dr Mark Crimmin will receive the Harrison-Meldola Memorial Prize. The Membrane Biophysics Platform team have also been recognised with the Rita & John Cornforth Award Professor Cass’s work focuses on the interface of chemistry He combines biological molecules with nanomaterials to produce diagnostic devices for human These will serve to enhance the quality of life for those suffering from chronic illness and also contribute to improved food security and animal welfare The Sir George Stokes Award is awarded for outstanding and sustained contributions to analytical science by someone demonstrably working in a complementary field which has led to developments of seminal importance to chemical analysis Professor Cass said: “I’m honoured and rather humbled by receiving the Sir George Stokes award I’ve had the privilege and benefit of working with many highly talented individuals; as mentors The achievements recognised by this award are in no small measure down to their guidance Dr Crimmin’s work focuses on chemical techniques that could be used to solve global challenges he investigates ways to transform environmental pollutants into chemicals that could be used in pharmaceuticals The Harrison–Meldola Memorial Prize is awarded for the most meritorious and promising original investigations in chemistry and published results of those investigations Dr Crimmin said: “I am delighted with the recognition of the group’s work and deeply grateful to the talented members of my research group.” The Membrane Biophysics Platform engineer new membrane structures for everything from pharmaceutical products to artificial cells that mimic their biological counterparts The Rita & John Cornforth Award is awarded to scientists working in collaborative research teams between the chemistry and life sciences disciplines The Membrane Biophysics Platform team receives £2000 Dr Robert Law and Professor John Seddon said: “We are delighted to be awarded the RSC Rita and John Cornforth Award recognising our achievement in building a community of scientists to understand the behaviour of membranes We are looking forward to building on our success to further drive forward innovation and the application of soft membrane materials.” chief executive of the Royal Society of Chemistry said: “It is an honour to celebrate the innovation and expertise of our community through our prizes and awards We know that chemistry can be a powerful force for good and quality research and communication of that research are more important than ever before “Our charitable mission is to advance excellence in the chemical sciences and we are proud to celebrate our inspiring and influential winners Image of medal credit: Andy Mabbett/Wikimedia Creative Commons Five individuals and two teams from the University of Oxford have received prestigious prizes from the Royal Society of Chemistry today The Research and Innovation Prizes celebrate brilliant individuals across industry and academia The Horizon Prizes celebrate the most exciting contemporary chemical science at the cutting edge of research and innovation They are for teams or collaborations who are opening up new directions and possibilities in their field through ground-breaking scientific developments Chief Executive of the Royal Society of Chemistry said: ‘Some of the most incredible work in chemical science is carried out by teams and collaborations who use their diversity of thought experience and skills to deliver astonishing results These synergies are often at the very forefront of expanding our understanding of the world around us and why our judges have such a difficult job selecting winners for our Horizon Prizes.’ Molecular Flow Sensor team – Analytical Division Horizon Prize The Molecular Flow Sensor Team, a multidisciplinary team which is a collaboration between chemists, physiologists, computer modellers, clinicians at Oxford University Hospitals NHS Trust won the prize for the development of a novel device for lung function measurement: a molecular flow sensor for non-invasive breath analysis to provide measurements of respiratory disease and cardiac output who led the electronic development of the sensor at the Department of Chemistry said: ‘Designing the Molecular Flow Sensor has been really rewarding To see the work carried out over many years by Professor Gus Hancock and Professor Grant Ritchie develop into a real-world application with the potential to help many people shows the importance of this type of research.’ This sensor has been used as a tool in several respiratory medical studies including measuring the lung function of asthma and cystic fibrosis sufferers as well as for investigations into long Covid All the results so far point to the effectiveness of the sensor in early diagnosis and management of lung disease Team Nanobodies – Chemistry Biology Interface Division Horizon Prize Based across The Rosalind Franklin Institute Team Nanobodies has won a Horizon Prize for the development of tools to help fight Covid-19 Team Nanobodies’ research has shown that nanobodies – a smaller simple form of antibody generated by llamas and camels – can effectively target the SARS-CoV-2 virus that causes Covid-19 They found that short chains of the molecules which can be produced in large quantities in the laboratory significantly reduced signs of the Covid-19 disease when administered to infected animal models Professor Jim Naismith of Team Nanobodies said: ‘This project was an amazing example of teamwork everyone had their own role to play and they were able to slot into the team and drive this work forward The biggest challenge of this project was to keep up morale a lot of this work was done during the first lockdown when no one really knew what was going to happen The problem felt urgent and the team wanted to move as fast as possible to make an impact but it wasn’t always that easy.’ said: ‘Great science changes the way we think about things – either through the techniques used the products that emerge or even in how we interact with the world and those around us it also allows us to reflect on the incredible people involved in this work and how they have achieved their results ‘Although we are in the midst of negotiating a particularly turbulent and challenging era it is important to celebrate successes and advances in understanding as genuine opportunities to improve our lives The work of our Research & Innovation Prize winners is a fantastic example of why we celebrate great science and we’re very proud to recognise their contribution today.’ Dr Emily Flashman – Norman Heatley Award Dr Emily Flashman is recognised for her work on the elucidation of molecular mechanisms of oxygen-sensing enzymes in plants and animals in particular around revealing the structural and kinetic properties of plant cysteine oxidases Finding inhibitors for plant oxygen-sensing enzymes or engineering changes to their structure and mechanism could slow their activity and help plants survive flooded (low oxygen) conditions for longer This will be important in generating crops that are more tolerant of stresses associated with climate change Professor Laura Herz – Environment, Sustainability and Energy Division Mid-career Award Professor Laura Herz is recognised for her pioneering work advancing the development of solar cells through fundamental understanding of electronic structural and chemical properties of next-generation light-harvesting materials Professor Herz’s work is helping our understanding of how the energy provided by sunlight can be converted into electricity in solar cells based on new absorber materials Such advances in solar cells are needed so we can make the switch to renewable energy generation affordable: to address climate change and for energy security Professor Volker Deringer – Harrison-Meldola Memorial Prize Professor Volker Deringer is recognised for his innovative contributions to the modelling and understanding of amorphous materials Amorphous (non-crystalline) materials are important for many modern technologies: for example encoding ‘ones’ and ’zeros’ in digital memories Professor Deringer's team is particularly interested in leveraging machine-learning methods to enable new insights in materials chemistry Professor Peter Bruce – Longstaff Prize Professor Peter Bruce is recognised for his pioneering research on the chemistry of materials with applications in renewable energy leading to fundamental changes in our understanding of solid-state electrochemistry The main focus of Professor Bruce’s work is to develop a fundamental understanding of the properties of materials and the processes taking place in batteries and use this knowledge to improve performance for example increasing the range of an electric vehicle Professor Timothy Donohoe – Tilden Prize Professor Timothy Donohoe is recognized for his innovative development of catalytic methods that activate organic molecules by redox processes Professor Donohoe’s work concentrates on making carbon-carbon bonds which provide the skeleton or framework of a vast array of molecules Some of these have fascinating and useful properties (for use in pharmaceuticals The Royal Society of Chemistry’s Prizes portfolio is one of the oldest and most prestigious in the world More information is available at rsc.li/prizes You can view all news or browse by category Our Department of Chemistry is celebrating after two of its academics were awarded prestigious Royal Society of Chemistry (RSC) awards Professor Saiful Islam and Dr Aron Walsh were both recognised in the latest round of awards to be announced by the RSC for their work into new sustainable energy materials. The annual RSC awards recognise achievements by individuals teams and organisations in advancing chemical sciences Recipient of the 2013 Sustainable Energy Award was selected for his outstanding modelling studies into energy materials for new generations of lithium batteries and solid oxide fuel cells he said: “I am delighted to receive this award and would like to acknowledge my fantastic research group at Bath We are using state-of-the-art modelling techniques to develop sustainable materials for rechargeable batteries with potential use in new hybrid or electric vehicles.” Royal Society University Research Fellow and Reader in the department who received the Harrison-Meldola Memorial Prize was recognised for his work into the design of new compounds to convert solar energy The prize is awarded to a scientist under the age of 32 for the most original and commendable investigation in chemistry Dr Walsh commented: “I am truly honoured to receive the prize It is an exciting time to work in the Department of Chemistry where the sense of community and excellence has really helped my research progress to this level.” Our Centre for Sustainable Chemical Technologies to which the Department of Chemistry is a key contributor has rapidly become an important hub for sustainable chemistry in the UK Head of the Department and Director of the Centre for Sustainable Chemical Technologies Matthew Davidson added: “On behalf of all colleagues in the Department and the Centre I would like to offer my warmest congratulations to Saiful and Aron It is always gratifying to receive national recognition for our research but to have two such prestigious awards in one year in the area of energy materials is a special achievement and one that highlights the strength in depth we have in sustainable chemical technologies.” Darren Rafferty will be the sole Irish rider when the Baby Giro rolls out of Gradara in central Italy on Saturday morning ahead of seven stages of racing The 18-year-old has been selected for the Hagens Berman Axeon team for the race in what is his first season in the U23 ranks He goes into the event riding the crest of a wave after taking his first UCI-ranked international win at Strade Bianche di Romagna (1.2U) two weeks ago Since then he has ridden solidly in a series of one-day races in Italy He placed 21st in Coppa della Pace-Trofeo F.lli Anelli (1.2U) 14th in Trofeo Città di Meldola-GP AWC Event (1.2) and was 13th in Coppa Zappi-Trofeo Hotel Antico Borgo (1.2U) is regarded as one of the best development teams in the world It goes into the event with a strong line-up Apart from its Irish rider having recently won a major event American Matthew Riccitello won the Istrian Spring Trophy earlier this year Britain’s Leo Hayter – brother of Ethan of Ineos Grenadiers fame – was 2nd in the recent Trofeo Città di Meldola-GP AWC (1.2) Rafferty’s 19-year-old Danish team mate Kasper Andersen was the European junior road race champion two years ago while the team’s Spanish rider was national junior road race and TT champion last year Four of the five riders on the Hagens Berman Axeon team are either first or second year U23s meaning they are relatively new to this level of racing especially as Covid-19 wiped out so many international racing opportunities last year And while Rafferty’s goes into this Baby Giro to learn his recent win proves he can take his chance if and when it comes just like Ben Healy when he claimed the final stage last year The race starts with a flat stage on Saturday; some 164.9km from Gradara to Argenta before a slightly lumpier stage 2 on Sunday and the first uphill finish of the race on stage 3 on Monday is France’s new star Romain Grégoire (Equipe Continentale Groupama-FDJ) while he has won all around him in Europe so far this year the HC summit finish on stage 6 – 18.6km averaging 8.5 per cent to Colle Fauniera – is likely to reveal some new stars of the future We’re determined to make stickybottle.com much better for your enjoyment So become a ‘Stickybottle Supporter’ now from just €5 per month We’ve grown our audience significantly in recent years but the advertising market has become harder and harder each year In order to survive and grow – and create much better content – we need to develop an income from our readers By signing up to become a ‘Stickybottle Supporter’ you’ll be helping to secure independent coverage of Irish cycling for years to come Every cent collected from readers will be used to directly fund content Sign Up have been recognised in this year's Royal Society of Chemistry (RSC) awards UCL's Ivan Parkin has won the Griffith Medal of the Institute of Materials UCL's Sally Price has been awarded one of the Royal Society of Chemistry's Interdisciplinary Prizes for 2015 She has been recognised for her pioneering work at the interface between chemistry and other disciplines She now specialises in Computational Chemistry exploring how molecules interact with each other to form solids solutions and act as drug molecules depends on their charge density which can be calculated using the laws of quantum mechanics Sally has been developing computer programs to predict how organic molecules crystallise and the resulting properties She explains: "These programs test our fundamental understanding of the process of crystallisation and could help with the design of new organic materials with specific properties such as could be used in new electronic devices Sally has enjoyed working with scientists in the pharmaceutical industry testing whether her program calculations can help discover new crystalline forms of drug molecules with the aim of improving the design of pharmaceutical products and their manufacture Chief Executive of the Royal Society of Chemistry said: "It is always a pleasure to recognise excellence in the chemical sciences and I am pleased to acknowledge the illustrious achievements of our prize and award winners this year our winners are the very best in their fields and they can be very proud to follow in the footsteps of some of the most influential and important scientists around the world chemistry and the chemical sciences are vital in responding to some of humanity's biggest challenges and our prize and award winners are at the forefront of meeting that challenge." Prize winners are evaluated for the originality and impact of their research The awards also recognise the importance of teamwork across the chemical sciences Prof Price praised the contribution of her team to the award She said: "The award is recognising strong interdisciplinary collaborations within UCL as well as with different universities and industry through the CPOSS project It started nearly 20 years ago when I formed the essential experimentalist/theory partnership with Prof Derek Tocher (Chemistry) and  we expanded into projects with the late Prof Alan Jones (Chemical Engineering) benefitted from computational infrastructure development with Profs Anthony Finklestein and Wolfgang Emmerich (Computer Science) and Prof Richard Catlow Our current EPSRC project is working with Prof Simon Gaisford in UCL Pharmacy There are many other staff and students within UCL who are contributing to the interdisciplinary work on controlling and predicting the organic solid state which this prize recognises UCL's David O Scanlon has been recognised with the Harrison-Meldola Memorial Prize 2015 Inorganic and Materials Chemistry at the Department of Chemistry in UCL The prize recognises his development and application of computational techniques to understanding and predicting the properties of functional semi-conductors for energy applications He completed a PhD in Chemistry at Trinity College Dublin in 2011 and now leads the Materials Theory Group at UCL The group comprises three PhD students and three Master students who use Computational Chemistry techniques to understand and predict the behaviours of solid state materials primarily for electronic and renewable energy applications The group works on understanding the fundamental properties of the materials used in the screens of smart phones tablets and televisions and the materials used in solar cells and how these materials can be tweaked to improve performance He says: "I am delighted and humbled to accept the Harrison-Meldola Memorial Prize for 2015 This award recognizes work carried out with a myriad of excellent collaborators as well as with a host of dedicated and talented students This prize showcases the importance of predictive modelling of solid state materials and I am excited to watch the future development of this emerging field." Minerals and Mining has awarded this year's Griffith Medal to Prof Ivan Parkin who is Head of the Department of Chemistry at UCL Ivan is a mid-career scientist whose whole career has been devoted to the development of new methods to make characterise and functionally test materials His work covers solid-state chemistry for bulk materials thin film coatings through to antimicrobial polymers The work is characterised by innovative synthetic insight the development of new classes of materials and the development of fundamental understanding His work has already had an immediate commercial He is cited in the world's top 600 materials scientists and in the world's top chemists lists based on ESI Thomson analysis He has more publications in the Journal of Materials Chemistry than any other author The MAPS Faculty Focus is published monthly and contains news Newsletter Archive The Faculty participates in a number of open days throughout the academic year including the UCL Undergraduate Open Days and the UCL Graduate Open Day Register your interest Professor Ivan Parkin - Dean, UCL Faculty of Mathematical and Physical Sciences"I fully support the aims of the Friends of Out@UCL campaign. I have personal experience of the need for such a campaign and the difficulties that the LGBTQ+ community face." Read more... Online exhibition of historic space photos from the faculty's planetary science archives See the photos Alberto Zaccheroni is an Italian football (soccer) manager who has a net worth of $15 million dollars Zaccheroni is best known for having managed a number of top clubs in Serie A and having won a scudetto with A.C He is renowned also for his unconventional and trademark 3–4–3 tactical system Zaccheroni quit playing football at an early age due to an injury Alberto Zaccheroni started his managerial career at the relatively young age of 30 with the team Cesenatico he joined with Boca San Lazzaro for a season then making q move to Baracca Lugo in 1988 He spent two years managing this club then moved to Venezia in 1990 He moved to Bologna for a season in 1993 then on to coaching the team of Cosenza in 1994 for a season He signed with Udinese in 1995; he led the team to place third in the league and qualified for the UEFA Cup Alberto signed the contract with the Italian giants AC Milan Zaccheroni went three seasons without a club after which he had a contract with Juventus and from there he was appointed as the new manager of the Japan National Football Team He had a good start and career with Japan and led the Japanese team to win the 2011 AFC Asian Cup and 2013 EAFF East Asian Cup He also led the Japanese Football Team to qualify in 2014 World Cup in Brazil © 2025 Celebrity Net Worth / All Rights Reserved